We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Covering thalidomide, lenalidomide, and pomalidomide: temporary guidance for pregnancy prevention arrangements for patients taking them during COVID-19
Guidance for industry on flexible approaches to regulation we are taking during the COVID-19 outbreak.
Information for healthcare professionals on pertussis (whooping cough).
Information for clinicians on diagnosis and notification of Shiga toxin-producing Escherichia coli (STEC) and haemolytic uraemic syndrome (HUS).
Advice and guidance on the health needs of migrant patients for healthcare practitioners.
These forms are for GPs or other clinicians to fill out, to follow up cases of invasive haemophilus influenzae disease.
The characteristics, diagnosis, treatment, and epidemiology of group B streptococci.
Haemophilus influenzae type b (Hib): immunisation information for public health professionals, including updates.
TACO is one of the most common causes of transfusion-related deaths in the UK and cases have increased substantially in recent years. Identifying risk factors for TACO prior to transfusion allows initiation of appropriate mitigating measures.
UK Health Security Agency's laboratories provide a comprehensive range of microbiological tests and services.
Information about when you need to submit substantial amendments to a clinical trial including changes to the trial sponsor or legal representative, Investigational medicinal product certification and importation.
An overview of the future requirements for rapid COVID-19 diagnostic assays for antigen lateral flow devices.
Data on the real-world efficacy of the COVID-19 vaccines.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. We’ll send you a link to a feedback form. It will take only 2 minutes to fill in. Don’t worry we won’t send you spam or share your email address with anyone.